spacer
home > epc > Spring 2013
PUBLICATIONS

European Pharmaceutical Contractor

epc
Spring 2013

   
Text
PDF
bullet
Business and Finance
Annual Review

Back to the Future


EPC editor Graham Hughes runs through the changes that have occurred in the business side of the industry over the past 12 months, and gives some predictions for how the market may develop in the coming year.
 
view
download pdf
bullet
Clinical Trials
Imaging

Future Vision

Gregory Goldmacher, David Raunig and James Conklin at ICON Medical Imaging examine the possibility of the FDA decentralising imaging views in clinical trials. Many uncertainties are still to be resolved, but what are the likely implications for sponsors?
 
view
download pdf

Logistics

Real World Simulations

Richard Wood at DS Smith Plastics Cool Logistics assesses some of the most ground-breaking new developments in the world of heathcare packaging, including simulation and virtual prototyping.

 
view
download pdf
bullet
Legal & Regulatory
Clinical Trial Regulations

A New Chapter

Markus Hartmann at European Consulting & Contracting in Oncology outlines proposals to overhaul the European Clinical Trials Directive, correcting some of the faults found in the current legislation.
 
view
download pdf
Good Clinical Laboratory Practice

On Reflection

Good manufacturing practice is essential in drug development and clinical trials. Stephan Wnendt at MLM Medical Labs outlines some of the key factors that must be taken into account.
 
view
download pdf
bullet
Clinical Research
Imaging

A Paradigm in Evolution


Chronic diseases, such as Alzheimer’s, could be detected earlier using molecular imaging techniques. J Michael O’Neal, James A Strafaci, Robert Scarimbolo and Ronald L Van Heertum at CoreLab Partners explain what this could mean for clinical research.
 
view
download pdf
bullet
Science & Innovation

Innovation


Putting Intriguing Ideas to Work


 

Justin Jones at BBK Worldwide shares some insider information as to what companies need to focus on to continue to develop in the industry, as well as highlighting some of the key questions they should be asking.

 
  
 
view
download pdf
bullet
LABS & Logistics
Logistics

Real World Simulations

Richard Wood at DS Smith Plastics Cool Logistics assesses some of the most ground-breaking new developments in the world of healthcare packaging, including simulation and virtual prototyping.
 
view
download pdf
bullet
Central Labs
Central Labs

Good Fortune


In the first of a two-part article, industry reporter Nick Charles takes us on a journey to China to discover why the country should be of particular interest to CROs hoping to build an alliance.
 
view
download pdf
bullet
Review
Industry Insight

Editor's Letter

Graham Hughes introduces this quarter's EPC, taking a look at the possible future of the pharmaceutical industry and what businesses need to focus on to progress.
 
view
download pdf
In Conclusion

Eyes on the Prize


Graham Hughes delves into the world of Nobel Prizes and considers a pattern that seems to be emerging.
 
view
download pdf
Book Review

A Methodological Approach


Graham Hughes reviews Statistics in Medicine by Robert H Riffenburgh, and explains why he would recommend it to anyone with a keen interest in the subject.
 
view
download pdf
bullet
Regional Focus
Regional Focus

Russian Revolution

Chris Baker from Samedan Ltd investigates some of the changes that are occuring in Russia. This giant is emerging from its slumber and could become one of the major players of the pharmaceutical world.

 
view
download pdf

Research and Development
Innovation in R&D

Science Fiction, Not Science Fact

Matt Kingdon and Jon Platt at ?What If! explore some of the ways in which pharmaceutical businesses can try to stimulate innovation in R&D, as well as some of the pitfalls they can fall victim to.

 
view
download pdf
Life Sciences Analysis

Paths to Progress

The life sciences industry must constantly evolve to avoid becoming stagnant and out of date. Heather Fraser at IBM sets out the three big Cs that face the industry: challenges, choices and change.

 
view
download pdf

Medical Writing
Patient Information

Mind the Gap


Instructions on medication can often be misinterpreted by patients. Lisa Chamberlain James at Trilogy looks at some possible solutions for how this serious problem can be avoided.
 
view
download pdf

Interview
Interview: Martin Robinson

Striking the Right Chord

EPC learns about the current role that the International Academy of Clinical Research is playing, and finds out more about its recent meeting with the UK Home Secretary.
 
view
download pdf
Interview: Colin Stanley

An Inside Look

The President of DOCS speaks to EPC about his role in the pharma world and divulges his forecasts for 2013.
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

Quanticate Partners with CluePoints to Offer Data Quality Oversight capabilities

Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints as part of its new Data Quality Oversight service.
More info >>

White Papers

Pharmacovigilance and Risk Management Information in Centralised Applications in the EU

United BioSource Corporation (UBC)

Getting a new medication approved for the EU market through the centralised procedure can be complex and needs expertise. The new EU pharmacovigilance legislation (Good Vigilance Practice, GVP) is now in effect and applicants need to be fully compliant. It is critical to have a thorough understanding of the regulatory process and requirements, and the expectations with regards to the pharmacovigilance system and the risk management plan. Ensuring consistency and an appropriate level of detail in the documentation submitted as part of the approval process will help prevent unnecessary delays.
More info >>

Industry Events

6th Annual Single Cell Analysis Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its 6th Annual Single Cell Analysis Congress taking place on 8-9 November 2018 in London.  Part of the Genomics & Synthetic Biology Series UK, the congress will bring together over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement